Friday 6 November 2026 Export NTRA’s income statement to Excel — free account

Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.

Revenue: +34.1%
EPS: +34.4%
Free cash flow: −85.8%
Total debt: −0.06%

Quarter to September 2026, against a year earlier

316.48 47.28 −13.00%

Follow NTRA

Alert me

Market cap: $52.4B
P/E: 0.0×
Fwd P/E: −289×
Dividend yield: —
F-score: 6/9
Altman Z: 26.84
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Natera, Inc. 8-K filed Jul 6, 2026

Period ended Jul 1, 2026 · Filed Jul 6, 2026 · accepted 4:05 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers

Red flags

Officer departure Jul 6, 2026
Natera, Inc. reported the departure of an officer or director

8-K filed Jul 6, 2026 · The filing · sec.gov